Oncoinvent

company

About

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$6M
Industries
Biotechnology,Chemical,Life Science
Founded date
Aug 10, 2010
Number Of Employee
11 - 50
Operating Status
Active

Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$31M kr250M
Oncoinvent has raised a total of $31M kr250M in funding over 2 rounds. Their latest funding was raised on Jun 29, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2021 Series Unknown kr250M 2 Detail
May 19, 2020 Series Unknown $6M 4 Detail
Feb 9, 2017 Series Unknown $25M 1 Detail

Investors

Number of Lead Investors
Number of Investors
6
Oncoinvent is funded by 6 investors. Geveran Trading and MP Pensjon are the most recent investors.
Investor Name Lead Investor Funding Round
Geveran Trading Series Unknown
MP Pensjon Series Unknown
CGS Holding Series Unknown
Alpine Capital AS Series Unknown
Helene Sundt Series Unknown
Sciencons Series Unknown